Phase I dose-escalation study of tumor necrosis factor-alpha and concomitant radiation therapy.

The cancer journal from Scientific American

Volumn 1, Issue 3, 1995, Pages 204-209

  Hallahan, D E ^a   Vokes, E E ^a   Rubin, S J ^a   O'Brien, S ^a   Samuels, B ^a   Vijaykumar, S ^a   Kufe, D W ^a   Phillips, R ^a   Weichselbaum, R R ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; FEMALE; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; NEOPLASM; PHASE 1 CLINICAL TRIAL; RADIATION RESPONSE;

ADULT; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; MALE; NEOPLASMS; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0000546442     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)